AbInitio Bio

San Francisco, United States

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

$500K raised

May 2026

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AbInitio Bio raised?

AbInitio Bio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2026.

Who are AbInitio Bio's investors?

AbInitio Bio's investors include Y Combinator.

Where is AbInitio Bio headquartered?

AbInitio Bio is headquartered in San Francisco, United States.

What does AbInitio Bio do?

AbInitio Bio develops AI foundation models for biologic drug manufacturability and process optimization.

What stage is AbInitio Bio at?

AbInitio Bio is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 22, 2026.

MLA

"AbInitio Bio — Funding & Investors." VCBacked, May 22, 2026, https://www.vcbacked.co/company/abinitio-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). AbInitio Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/abinitio-bio

Wikipedia (cite web)

{{cite web |title=AbInitio Bio — Funding & Investors |url=https://www.vcbacked.co/company/abinitio-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 22, 2026.